CFDE Data Portal | Search MRPL35P2

	Label	Description
	MRPL35P2 associations Collection (Entity type)	Associations for MRPL35P2_associations
	MRPL35P2 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	MRPL35P2 Gene (Entity type)	ENSG00000232075 - mitochondrial ribosomal protein L35 pseudogene 2
	GSE151090 verteporfin 2 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE226249 pirfenidone HL 5 v 8 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE224105 GSE224108 zearalenone 3 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE213650 everolimus 0 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GPR149 IDG GPCR ARCHS4 coexpression Gene Set (Entity type)	A Gene Set from IDG
	GTEx Kidney 20-29 vs 60-69 Down Gene Set (Entity type)	A Gene Set from GTEx
	GSE130396 neratinib 0 v 6 human dn Gene Set (Entity type)	A Gene Set from LINCS

MRPL35P2 associations

Associations for MRPL35P2_associations

MRPL35P2 associations.tsv

A file from IDG as part of the Harmonizome project

MRPL35P2

ENSG00000232075 - mitochondrial ribosomal protein L35 pseudogene 2

GSE151090 verteporfin 2 v 1 human dn

A Gene Set from LINCS

GSE226249 pirfenidone HL 5 v 8 human up

A Gene Set from LINCS

GSE224105 GSE224108 zearalenone 3 v 2 human dn

A Gene Set from LINCS

GSE213650 everolimus 0 v 2 human dn

A Gene Set from LINCS

GPR149 IDG GPCR ARCHS4 coexpression

A Gene Set from IDG

GTEx Kidney 20-29 vs 60-69 Down

A Gene Set from GTEx

GSE130396 neratinib 0 v 6 human dn

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.